Chicago Cancer Genome Project Clinically Characterizing Tumors; May Work with Complete Genomics
January 26, 2010
Chicago Cancer Genome Project Clinically Characterizing Tumors; May Work with Complete Genomics
The researchers plan to sequence and compare clinically different tumors — those that respond to chemotherapy versus those that do not, for example — in order to improve treatment and diagnosis.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Wash U, St. Jude Will Sequence 600 Pediatric Cancer Genomes on Illumina's GA and HiSeq
January 26, 2010 / In Sequence - Clinical Genome Sequencing Requires Better Standards for Accuracy, Completeness, NHGRI Team Says
August 24, 2011 / Clinical Sequencing News - Q&A: ARUP Labs' Karl Voelkerding Discusses Bringing Next-Gen Sequencing to the Clinical Setting
March 30, 2010 / In Sequence - Complete Genomics CEO Tells Employees BGI Buy Anticipated to Close in Q1 2013
December 13, 2012 / GenomeWeb Daily News - Illumina and University of Oxford to Sequence 500 Human Genomes to Inform Diagnosis, Treatment
August 3, 2011 / Clinical Sequencing News